May 3, 2012
Recent News
View All
Wednesday, May 15, 2013
EntreMed Reports First Quarter 2013 Financial Results
Monday, May 6, 2013
Patent Issued In China For EntreMed’s Lead Drug Candidate ENMD-2076
Friday, May 3, 2013
Patent Issued In U.S. For EntreMed’s 2ME2 In Rheumatoid Diseases
Friday, April 5, 2013
EntreMed Announces Changes to Board of Directors and CEO Appointment
Thursday, March 21, 2013
EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
Stay Informed
Enter your e-mail address to receive press releases electronically. (Manage your subscription)